Literature DB >> 3053753

IgM antibody responses to the circumsporozoite protein in naturally acquired falciparum malaria.

A E Brown1, H K Webster, S Tulyayon, A Suvarnamani, R A Wirtz, P Sookto.   

Abstract

The circumsporozoite (CS) protein on the surface of sporozoites is the major target for antibody response(s) to the infective stage of the malaria parasite. Sera from malaria endemic areas contain both IgM and IgG antibodies that react with a dominant epitope in the tetrapeptide repeat region of the CS protein. In order to characterize the IgM CS antibody response in Plasmodium falciparum (PF) malaria, a prospective study was conducted in Thai Rangers. Variable IgM responses against the CS protein were detected in 81% of 47 PF-infected subjects. Similar to IgG response kinetics, IgM levels rose to a peak 6-10 days after detection of parasitemia and showed an apparent serum half-life of less than 25 days. The classic difference in isotype ratio (IgG/IgM) between primary and secondary antibody responses was observed to blood-stage, but not CS, antigens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053753     DOI: 10.1007/BF00917149

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  Kinetic constraints on the development of a malaria vaccine.

Authors:  A Saul
Journal:  Parasite Immunol       Date:  1987-01       Impact factor: 2.280

2.  Detection of antibodies in human sera to the repeating epitope of the circumsporozoite protein of Plasmodium falciparum using the synthetic peptide (NANP)3 in an enzyme-linked immunosorbent assay (ELISA).

Authors:  G H Campbell; A D Brandling-Bennett; J M Roberts; F H Collins; D C Kaseje; A M Barber; A Turner
Journal:  Am J Trop Med Hyg       Date:  1987-07       Impact factor: 2.345

3.  Plasmodium berghei: T cell dependence of sporozoite-induced immunity in rodents.

Authors:  G L Spitalny; J P Verhave; J H Meuwissen; R S Nussenzweig
Journal:  Exp Parasitol       Date:  1977-06       Impact factor: 2.011

4.  Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

Authors:  R F Anders
Journal:  Parasite Immunol       Date:  1986-11       Impact factor: 2.280

5.  Vaccination against Plasmodium falciparum: a negative result.

Authors:  R S Bray
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

6.  Role of T cells in the development of memory B cells. Quantitative and qualitative analysis.

Authors:  D E Lafrenz; T L Feldbush
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

7.  Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite.

Authors:  N Yoshida; R S Nussenzweig; P Potocnjak; V Nussenzweig; M Aikawa
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

8.  Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.

Authors:  S L Hoffman; R Wistar; W R Ballou; M R Hollingdale; R A Wirtz; I Schneider; H A Marwoto; W T Hockmeyer
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245

9.  Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.

Authors:  G Del Giudice; H D Engers; C Tougne; S S Biro; N Weiss; A S Verdini; A Pessi; A A Degremont; T A Freyvogel; P H Lambert
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

10.  Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.

Authors:  M F Good; J A Berzofsky; W L Maloy; Y Hayashi; N Fujii; W T Hockmeyer; L H Miller
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.